EGFR/HER2/CDK9-IN-1
EGFR/HER2/CDK9-IN-1 (Compound 4) is a potent inhibitor of EGFR/HER2/CDK9 with IC50s of 90.17, 131.39, and 67.04 nM, respectively. EGFR/HER2/CDK9-IN-1 exhibits remarkable antitumor activity[1].
Product Specifications
CAS Number
879730-44-6
UNSPSC
12352005
Target
CDK; EGFR
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/egfr-her2-cdk9-in-1.html
Solubility
10 mM in DMSO
Smiles
O=S(C1=CC=C(CCN2C(SCC3=CC=CC=C3)=NC4=C(C=CC=C4)C2=O)C=C1)(N)=O
Molecular Formula
C23H21N3O3S2
Molecular Weight
451.56
References & Citations
[1] El-Azab AS, et al. Antitumor activity, multitarget mechanisms, and molecular docking studies of quinazoline derivatives based on a benzenesulfonamide scaffold: Cell cycle analysis. Bioorg Chem. 2020;104:104345.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TP700138 20 µg
Eph receptor A2 (EPHA2) (NM_004431) Human Recombinant Protein
Sign In for Pricing
View Details 
